Corgenix Reports Initial Phase Completion of a Multi-Year Pivotal Clinical Trial (OTCMKTS:CONX, OTCMKTS:CRWE)

Corgenix Medical Corporation (CONX) Today, The Company is (0.00%) +0.000 at $.240 thus far (ref. google finance Delayed: 11:29AM EDT April 30, 2013). Corgenix Medical Corporation previously reported completion of a major phase of the collaborative effort to combat important viral diseases. The multi-year study, conducted primarily at the Kenema Government Hospital in Kenema, Sierra [...]